Catherine Guittet
Corporate Officer/Principal bei ADVICENNE
Profil
Catherine Guittet is currently the Head of Clinical Operations Department at Advicenne SA since 2008.
Prior to this, she worked as the Head of Patients Clinical Study Unit at SGS Aster SAS, Head of Clinical Department at Synt:em SA, Head of Project Management at Sanofi Aventis Participations SAS, and as a Principal at Merck Serono SAS.
Dr. Guittet holds a doctorate degree from L'Université d'Angers and an undergraduate degree from Université Paris Diderot-Paris 7.
Aktive Positionen von Catherine Guittet
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVICENNE | Corporate Officer/Principal | 01.01.2008 |
Ehemalige bekannte Positionen von Catherine Guittet
| Unternehmen | Position | Ende |
|---|---|---|
SGS Aster SAS
 SGS Aster SAS Miscellaneous Commercial ServicesCommercial Services SGS Aster SAS provides clinical pharmacology trials and bioanalytical drug development services. The company is based in Paris, France. The French company was founded in 1992 by John J. Thebault. SGS Aster was acquired by SGS SA on January 05, 2006. | Corporate Officer/Principal | - |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Corporate Officer/Principal | - |
Merck Serono SAS
 Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Corporate Officer/Principal | - |
Sanofi Aventis Participations SAS
 Sanofi Aventis Participations SAS Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis Participations SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the private company is Mathias Thibault. | Corporate Officer/Principal | - |
Ausbildung von Catherine Guittet
| L'Université d'Angers | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADVICENNE | Health Technology |
| Private Unternehmen | 5 |
|---|---|
SGS Aster SAS
SGS Aster SAS Miscellaneous Commercial ServicesCommercial Services SGS Aster SAS provides clinical pharmacology trials and bioanalytical drug development services. The company is based in Paris, France. The French company was founded in 1992 by John J. Thebault. SGS Aster was acquired by SGS SA on January 05, 2006. | Commercial Services |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
| Université Paris Diderot-Paris 7 | Consumer Services |
Sanofi Aventis Participations SAS
Sanofi Aventis Participations SAS Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis Participations SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the private company is Mathias Thibault. | Health Technology |
Merck Serono SAS
Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Health Technology |
